Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 19:3:100024.
doi: 10.1016/j.jhlto.2023.100024. eCollection 2024 Feb.

Pulmonary vascular dysfunction in systemic sclerosis

Affiliations

Pulmonary vascular dysfunction in systemic sclerosis

Mads Jønsson Andersen et al. JHLT Open. .

Abstract

Purpose: This study aimed to determine if any cases of pulmonary arterial hypertension (PAH) were missed using routine screening of systemic sclerosis (SSc). We assessed the potential benefits of adding the DETECT algorithm and invasive hemodynamic exercise testing into the local screening process in a Danish single-center cohort without known PAH.

Methods: Seventy-three patients with SSc (aged 60 ± 10 years; 56 (77%) females) underwent echocardiography. Among them, 24/73 had an elevated step 2 score of whom 3 had a high risk of pulmonary hypertension on echocardiographic assessment. Four patients declined right heart catheterization. Twenty patients (aged 62 ± 10 years, 13 (65%) females) underwent invasive hemodynamic assessment at rest. Nineteen patients participated in invasive hemodynamic exercise testing.

Results: At rest, 3/20 patients met the 2022 ESC guidelines for PAH (mean pulmonary arterial pressure (mPAP) >20 mm Hg, pulmonary arterial wedge pressure (PAWP) ≤15 mm Hg, and pulmonary vascular resistance >2 Wood units). According to the 2015 ESC guidelines, only 1/19 patients had PAH. During exercise, 18/19 experienced an mPAP of >30 mm Hg, with the majority (13/19) showing an abnormal pulmonary pressure-flow relationship >3 mm Hg/liter/min. Interestingly, 7 out of 9 patients with no pulmonary hypertension (PH) at rest had exercise-induced pulmonary hypertension. One-quarter of the patients had pulmonary hypertension associated with left ventricular dysfunction (group 2 PH, WHO classification).

Conclusions: In a Danish cohort of 73 patients with SSc already undergoing bi-annual PAH screening, applying the DETECT algorithm identified 3 patients meeting the 2022 ESC/ERS guideline criteria for PAH at rest, 1 of whom demonstrated increased PAWP with exercise. However, many patients exhibited an abnormal pulmonary vascular response to exercise and/or signs of group 2 PH.

Keywords: hemodynamic stress; invasive hemodynamics; pulmonary hypertension; right heart catherterization; systemic sclerosis.

PubMed Disclaimer

Figures

Fig. 1
Figure 1
Summarized flowchart of enrollment. Green rectangles represent flow of patients enrolled in the study. Blue rectangles represent main results of hemodynamics. Abbreviations: ∆mPA/∆CO, pulmonary pressure flow relationship; PAH, pulmonary arterial hypertension; PAWP, pulmonary arterial wedge pressure; SSc, systemic sclerosis.
Fig. 2
Figure 2
The slope of the increase in mean pulmonary arterial pressure (mPAP) relative to cardiac output (CO) at rest and peak exercise in (A) all systemic sclerosis (SSc) patients who underwent right heart catheterization during exercise and in (B) SSc patients with a normal resting mPAP (mPAP < 20 mm Hg). The solid line represents a mPAP/CO cut-off at 3 mm Hg/liter. Data points represent mean group values. Error bars reflect the SD.

Similar articles

Cited by

References

    1. Sweiss N.J., Hushaw L., Thenappan T., et al. Diagnosis and management of pulmonary hypertension in systemic sclerosis. Curr Rheumatol Rep. 2010;12:8–18. - PMC - PubMed
    1. Ioannidis J.P., Vlachoyiannopoulos P.G., Haidich A.B., et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med. 2005;118:2–10. - PubMed
    1. Hachulla E., Carpentier P., Gressin V., et al. Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study. Rheumatology (Oxford) 2009;48:304–308. - PMC - PubMed
    1. Khou V., Anderson J.J., Strange G., et al. Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry. Respirology. 2020;25:863–871. - PubMed
    1. Humbert M., Yaici A., de Groote P., et al. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum. 2011;63:3522–3530. - PubMed

LinkOut - more resources